Good morning :)
Place Order
Add to Watchlist

Camlin Fine Sciences Ltd

CAMLINFINE

Camlin Fine Sciences Ltd

CAMLINFINE
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹1,877 cr, stock is ranked 1,176
High RiskStock is 3.29x as volatile as Nifty
112.071.21% (-1.37)
112.071.21% (-1.37)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹1,877 cr, stock is ranked 1,176
High RiskStock is 3.29x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹1,877 cr, stock is ranked 1,176
High RiskStock is 3.29x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-13.192.19
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
30.763.471.33%

Forecast & Ratings

Detailed Forecast 
0%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Camlin Fine Sciences Limited is engaged in fine chemicals business. It provides antioxidants and shelf life extensions, aroma ingredients, performance chemical products and related solutions various industries.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 12.45%, vs industry avg of 6.09%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 1.63% to 1.94%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue493.61548.46732.33905.961,052.581,192.081,445.121,687.361,628.621,600.37
Raw Materialssubtract250.26294.26424.79495.45553.17566.17772.90916.28860.871,585.78
Power & Fuel Costsubtract47.4346.3561.4380.4276.3884.16123.01204.60124.31
Employee Costsubtract40.0561.0972.8787.8999.71120.38145.05162.62178.75
Selling & Administrative Expensessubtract52.7971.7676.3482.7896.1492.1882.9496.5893.35
Operating & Other expensessubtract11.5628.6369.1772.7888.54137.33130.4898.15322.01
Depreciation/Amortizationsubtract17.0621.8026.6528.9932.8044.2955.9662.5178.6179.94
Interest & Other Itemssubtract24.4430.5831.8040.9547.6342.4840.8066.2469.9773.46
Taxes & Other Itemssubtract14.205.16-1.0916.1227.8854.1333.2928.27-6.493.45
EPS3.72-1.11-2.630.052.504.104.273.32-5.72-8.49
DPS0.450.000.000.000.000.000.000.000.000.00
Payout ratio0.120.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

May 20PDF
Feb 8PDF
Feb 8PDF
Jan 5PDF
FY 2023

Annual report

PDF

Investor Presentation

May 22PDF
Feb 13PDF
Nov 12PDF
Aug 12PDF
FY 2024

Annual report

PDF

Investor Presentation

Sep 14PDF
Aug 11PDF
 

Peers & Comparison

Comparing 3 stocks from 
MaterialsSpecialty Chemicals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Camlin Fine Sciences Ltd-20.242.19
Gujarat Fluorochemicals Ltd105.217.710.07%
Vinati Organics Ltd61.398.060.37%
Akzo Nobel India Ltd43.6814.011.59%

Price Comparison

Compare CAMLINFINE with any stock or ETF
Compare CAMLINFINE with any stock or ETF
CAMLINFINE
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 1.08%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding48.02%4.23%0.00%0.81%46.93%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep10.12%1.61%0.99%1.69%1.01%0.81%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Camlin Fine Sciences Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
ICICI Prudential Smallcap Fund - Growth - Direct Plan

Growth
2.2962%0.50%-0.03%53/117 (-1)
ICICI Prudential Commodities Fund - Cumulative - Direct Plan

Growth
1.2414%0.91%-0.01%26/55 (+2)
ICICI Prudential Dividend Yield Equity Fund Direct Plan Growth

Growth
0.1201%0.05%-0.01%66/72 (-7)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

CAMLINFINE has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJul 28, 2016

Final
Final | Div/Share: ₹0.45

Dividend/Share

0.45

Ex DateEx Date

Jul 28, 2016

Cash Dividend

Ex DateEx DateJul 27, 2015

Final
Final | Div/Share: ₹0.45

Dividend/Share

0.45

Ex DateEx Date

Jul 27, 2015

Cash Dividend

Ex DateEx DateJul 24, 2014

Final
Final | Div/Share: ₹0.70

Dividend/Share

0.70

Ex DateEx Date

Jul 24, 2014

Cash Dividend

Ex DateEx DateAug 1, 2013

Final
Final | Div/Share: ₹0.60

Dividend/Share

0.60

Ex DateEx Date

Aug 1, 2013

Cash Dividend

Ex DateEx DateJul 23, 2012

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Jul 23, 2012

News & Opinions
Corporate
Camlin Fine Sciences schedules board meeting

Camlin Fine Sciences will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Board of Camlin Fine Sciences approves raising up to Rs 150 cr via rights issue

The Board of Camlin Fine Sciences at its meeting held on 10 September 2024 has approved the following: 1. Increase in authorised share capital of the Company and subsequent alteration to the Memorandum of Association of the Company. 2. Raising of fund by way of issue of equity shares of the Company of face value Re 1 each through Rights Issue for an amount not exceeding Rs 150 crore. Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Camlin Fine Sciences schedules board meeting

Camlin Fine Sciences will hold a meeting of the Board of Directors of the Company on 10 September 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Camlin Fine Sciences reports consolidated net loss of Rs 33.95 crore in the June 2024 quarter

Net loss of Camlin Fine Sciences reported to Rs 33.95 crore in the quarter ended June 2024 as against net profit of Rs 15.55 crore during the previous quarter ended June 2023. Sales declined 5.66% to Rs 395.85 crore in the quarter ended June 2024 as against Rs 419.60 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales395.85419.60 -6 OPM %4.589.23 - PBDT-3.3734.86 PL PBT-23.4816.08 PL NP-33.9515.55 PL Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Camlin Fine Sciences to convene board meeting

Camlin Fine Sciences will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live

Chennai Petroleum Corporation Ltd leads gainers in ‘A’ group

3 months agoBusiness Standard

Camlin Fine Sciences rises for sixth day in row

4 months agoBusiness Standard

Camlin Fine Sciences up 10% on acquiring Belgium based animal food firm

4 months agoBusiness Standard

Camlin Fine Sciences Q3 Results Review - Macro Challenges Continue To Impact Growth: Nirmal Bang

8 months agoBloomberg Quint

Camlin Fine Sciences - China Dumping A Near Term Hindering Factor: Nirmal Bang

10 months agoBloomberg Quint